Northwestern Mutual Wealth Management’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VKTX
Northwestern Mutual Wealth Management's VKTX Position: Q2 2026 in Review
Northwestern Mutual Wealth Management increased its Viking Therapeutics (VKTX) stake by 67% in Q2 2026, buying an estimated $18.7K and bringing the position to 1,445 shares worth $56.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2493.
Northwestern Mutual Wealth Management first reported a position in VKTX in Q1 2019 and has held it in 15 quarters since. The position peaked at $63.6K in Q4 2024. 432 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.
- Northwestern Mutual Wealth Management held 1,445 shares of Viking Therapeutics worth $56.4K as of Q2 2026.
- Northwestern Mutual Wealth Management bought 579 Viking Therapeutics shares in Q2 2026, an estimated $18.7K.
- Viking Therapeutics made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q2 2026, its #2493 holding.
- Northwestern Mutual Wealth Management first reported a position in Viking Therapeutics in Q1 2019 and has held it in 15 quarters since.
- Northwestern Mutual Wealth Management's Viking Therapeutics position peaked at $63.6K in Q4 2024.
- 432 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.
Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.